Healthleap, a clinical AI startup founded by South African siblings Josiah and Jemima Meyer, has raised $38 million in combined seed and Series A funding from Sequoia Capital, First Round Capital and Hummingbird Ventures. The Healthleap round puts three well-known venture firms behind a product built to find hospital patients whose conditions are being missed.
The funding was reported by Tom Jackson at Disrupt Africa on 19 October. The split between the seed and Series A rounds was not disclosed, and no lead investor was named.
What Healthleap's software does
Hospitals collect a large amount of data on every patient, but much of it is never read in full. Notes, lab results, vital signs, medication orders and problem lists sit in different parts of the electronic health record (EHR). Conditions that are common but easy to overlook can slip through.
Healthleap's platform reviews each patient's full record every morning, according to Disrupt Africa. It looks across notes, labs, vitals, orders and problem lists, flags patients at risk, and sends a risk score into the EHR screens that clinicians already use. Care teams can then see which patients need attention first, without opening a separate app.
The company started with one condition: malnutrition in hospital patients. It plans to add:
- congestive heart failure
- pressure ulcers
- a range of hospital-acquired infections
The traction behind the Healthleap round
Healthleap has shared two results from hospitals using the system. At one hospital, 39% more malnutrition cases were identified and treated. The company also cites $11 million in additional revenue at a single health system. Disrupt Africa's report does not make clear whether those two figures come from the same customer.
The revenue figure matters as much as the clinical one. In many hospital systems, especially in the United States, a correctly documented diagnosis changes how a hospital is reimbursed. A tool that finds undiagnosed malnutrition both improves care and recovers money the hospital was entitled to but not claiming. That combination is often what gets a hospital's finance team to approve a new software contract.
"Our goal is to help improve care and save lives by identifying those conditions now," co-founder and CEO Josiah Meyer said.
What the investors said
Alfred Lin of Sequoia Capital said Healthleap is focused on finding patients who are being missed and getting them care. Josh Kopelman of First Round Capital said his firm was drawn to the idea of every hospital using real-time AI to catch clinical risks that would otherwise be overlooked.
Where the $38 million will go
Healthleap plans to use the money in two ways:
- Expanding the platform to cover more conditions beyond malnutrition.
- Growing its engineering, sales, customer success and product teams.
The company sells to hospitals and health systems. Disrupt Africa's report does not say which countries its current customers are in, or whether African hospitals are among them.
What it means for African health tech
Healthleap was founded in 2022, which makes a $38 million raise in four years notable. Kenyan space startup Satlyt, which we covered when it raised $8 million to run AI on satellites, is another recent example of an African team raising money for a technically demanding AI product.
There are a few reasons this matters for the continent's ecosystem.
- Talent signal. Sequoia and First Round backing a South African-founded team at this stage tells other investors that clinical AI talent from the region can compete for top-tier capital.
- Product relevance. Malnutrition and hospital-acquired infections are serious problems in African hospitals too. If the product works with the EHR systems used locally, it could be adapted for African health systems later.
- The data question. Tools like this depend on hospitals having complete digital records. Many public hospitals in Africa still rely partly on paper, which limits how quickly this kind of AI can be used there.
Why hospitals buy tools like this
Clinical AI startups have often struggled to get past pilot projects. Hospitals are cautious about software that touches patient care, and busy clinicians resist anything that adds extra screens or logins. Healthleap's approach answers both concerns: it works on data the hospital already holds, and it puts its output inside the record system staff already use every day.
The choice of malnutrition as a first target is also practical. It is common among hospital patients, it affects recovery times, and it is frequently missed in busy wards. A tool that catches more of those cases gives clinicians something concrete to act on, and gives hospital managers a measurable result to show for the investment.
The questions to watch
The next test for Healthleap is whether it can repeat its malnutrition results for heart failure, pressure ulcers and infections, which are clinically different and carry more risk if the system gets it wrong. Hospitals will also want evidence that flags are accurate enough not to add alert fatigue for already busy nurses and doctors.
For now, the round gives the Meyer siblings the money and the investor names to find out. It also adds Healthleap to a short list of Africa-founded AI companies that have raised serious early capital from the top of the venture market.
